TIAA CREF INVESTMENT MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$61,222,000
+320.5%
384,925
+153.2%
0.04%
+258.3%
Q4 2018$14,560,000
-69.6%
151,999
-55.2%
0.01%
-25.0%
Q3 2018$47,942,000
+67.3%
339,410
+85.4%
0.02%
-15.8%
Q2 2018$28,658,000
-22.8%
183,084
-20.6%
0.02%
-24.0%
Q1 2018$37,142,000
+76.5%
230,595
+80.4%
0.02%
+78.6%
Q4 2017$21,048,000
+180.3%
127,790
+6.0%
0.01%
+180.0%
Q3 2017$7,508,000
-23.1%
120,514
-1.7%
0.01%
-28.6%
Q2 2017$9,760,000
+35.9%
122,554
+21.3%
0.01%
+40.0%
Q1 2017$7,180,000
+36.7%
101,027
-1.8%
0.01%
+25.0%
Q4 2016$5,252,000
+11.5%
102,867
+0.6%
0.00%
+33.3%
Q3 2016$4,709,000
+76.6%
102,265
+15.5%
0.00%
+50.0%
Q2 2016$2,667,000
+53.3%
88,521
+63.1%
0.00%
+100.0%
Q1 2016$1,740,000
-41.5%
54,273
+6.3%
0.00%
-50.0%
Q4 2015$2,976,000
+18.5%
51,046
-14.0%
0.00%0.0%
Q3 2015$2,511,000
-22.8%
59,328
+33.2%
0.00%0.0%
Q2 2015$3,252,000
+298.0%
44,545
+173.9%
0.00%
+100.0%
Q1 2015$817,000
+55.0%
16,261
+13.0%
0.00%
Q4 2014$527,000
+36.2%
14,396
+17.1%
0.00%
Q3 2014$387,00012,2970.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders